Scalable Synthesis of a Masked Thiophenol as an Air-Stable, Odorless Intermediate to the Aurora Kinase Inhibitor Tozasertib (VX-680)
Open Access
- 7 August 2026
- journal article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
Abstract
The use of thiophenols on process scales is fraught with challenges relating to their toxicity, malodor, and air sensitivity. We previously demonstrated that the Ni-catalyzed C–S coupling of aryl iodides and thiourea provides a discovery-scale route to S-aryl isothiouronium salts, which serve as bench stable, odorless, and highly crystalline surrogates of thiophenols. Here, we report the process optimization of this methodology for the synthesis of a key intermediate to kinase inhibitor tozasertib (VX-680). The corollary is a reduction in catalyst loading to 0.5 mol %, elimination of NMP solvent, and introduction of a direct crystallization, giving 95% yield on a 100 g scale.Keywords
Funding Information
- AstraZeneca
- Engineering and Physical Sciences Research Council (EP/R002452/1)
- UK Research and Innovation (MR/V022067/1)
- Studienstiftung des Deutschen Volkes
This publication has 46 references indexed in Scilit:
- On the Use of Differential Scanning Calorimetry for Thermal Hazard Assessment of New Chemistry: Avoiding Explosive MistakesAngewandte Chemie International Edition, 2020
- The Chalcogen Bond in Crystalline Solids: A World Parallel to Halogen BondAccounts of Chemical Research, 2019
- Synthesis of Air‐stable, Odorless Thiophenol Surrogates via Ni‐Catalyzed C−S Cross‐CouplingChemistry – A European Journal, 2019
- Analysis of US FDA-Approved Drugs Containing Sulfur AtomsTopics in Current Chemistry, 2018
- Sulfur-Containing AgrochemicalsTopics in Current Chemistry, 2017
- Pathways of Reactive Metabolite Formation with Toxicophores/‐Structural Alerts2012
- Aurora kinase inhibitors: Progress towards the clinicInvestigational New Drugs, 2012
- The discovery of the potent aurora inhibitor MK-0457 (VX-680)Bioorganic & Medicinal Chemistry Letters, 2009
- Structural basis for potent inhibition of the Aurora kinases and a T315I multi-drug resistant mutant form of Abl kinase by VX-680Cancer Letters, 2007
- Sulfur‐Containing Organics (Miscellaneous)2006